Elanco
Derek Trobaugh, Ph.D., is a Principal Research Scientist and Head of Antibody Discovery at Elanco since January 2020, previously serving as a Senior Research Scientist in the RNA Platform focusing on Discovery Virology and Biopharma. Prior to Elanco, Derek Trobaugh was a Research Assistant Professor at the University of Pittsburgh from 2012 to 2020 in the Department of Immunology, where significant contributions included leading the development of live-attenuated eastern equine encephalitis virus vaccine candidates and successfully acquiring external NIH grants. Prior experience includes a postdoctoral position where critical research on alphavirus pathogenesis was published in high-impact journals, alongside extensive mentoring and collaboration on multiple scientific publications. Academic credentials include a Ph.D. in Immunology and Virology from UMass Chan Medical School and a B.S. in Applied Biology from Rose-Hulman Institute of Technology.
This person is not in any teams
This person is not in any offices
Elanco
28 followers
Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for companion and food animals. The Company offers its products under four primary categories, such as Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine.